Document Detail

Urine free beta hCG and beta core in pregnancies affected by Down's syndrome.
MedLine Citation:
PMID:  8843469     Owner:  NLM     Status:  MEDLINE    
Urine beta core was shown in recent studies to be markedly elevated in pregnancies affected by Down's syndrome in the late second trimester. Free beta human chorionic gonadotropin (hCG) has also been shown to be the most discriminatory maternal serum marker of Down's syndrome. Since free beta hCG is rapidly cleared from the maternal circulation, we have carried out a study to evaluate whether free beta hCG is elevated in the urine of pregnancies affected by Down's syndrome and to investigate whether urine beta core or urine free beta hCG may be used as possible screening markers. Urine samples from 29 cases of Down's syndrome, three cases of trisomy 18, and 400 control pregnancies were analysed for the two prospective markers. Results were corrected for urine concentration by expressing marker concentrations at a fixed creatinine concentration and then expressing the results as multiples of the median for unaffected pregnancies of the same gestation. The median value of beta core in the Down's syndrome pregnancies was 2.35 compared with 2.47 for free beta hCG. Free beta hCG distributions were closely similar to those in maternal serum. Using free beta hCG, we predict Down's syndrome detection rates of 58 per cent at a 5 per cent false-positive rate. Using beta core, however, this rate fell to 41 per cent. Measurement of free beta hCG in urine may present a feasible route for screening pregnant populations, particularly where community-based obstetric care is the norm and/or if early first-trimester screening becomes a reality.
K Spencer; D A Aitken; J N Macri; P D Buchanan
Related Documents :
3133249 - The importance of human chorionic gonadotropin support of the corpus luteum during huma...
24371619 - Sentinel node procedure in vulvar carcinoma during pregnancy: a case report.
22115169 - Adrenal disease in pregnancy.
3287699 - Lack of genotoxicity with beta-carotene.
11920889 - Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein a ...
8761969 - Placental isoferritin as a marker of early abortion in pregnancies induced by in vitro ...
6163149 - The demonstration of two pregnancy-associated proteins with sp1 determinants in placent...
24498169 - Promoter dna methylation of farnesoid x receptor and pregnane x receptor modulates the ...
18680139 - Fetus-supporting flexible manipulator with balloon-type stabilizer for endoscopic intra...
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  Prenatal diagnosis     Volume:  16     ISSN:  0197-3851     ISO Abbreviation:  Prenat. Diagn.     Publication Date:  1996 Jul 
Date Detail:
Created Date:  1996-12-31     Completed Date:  1996-12-31     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8106540     Medline TA:  Prenat Diagn     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  605-13     Citation Subset:  IM    
Department of Clinical Biochemistry, Oldchurch Hospital, Romford, Essex, U.K.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biological Markers / urine
Chorionic Gonadotropin, beta Subunit, Human / metabolism,  urine*
Creatinine / metabolism,  urine
Down Syndrome / diagnosis*,  embryology
Fetal Diseases / diagnosis*,  embryology
Gestational Age
Normal Distribution
Peptide Fragments / metabolism,  urine*
Pregnancy Trimester, Second
Prenatal Diagnosis* / methods
Reference Values
Reg. No./Substance:
0/Biological Markers; 0/Chorionic Gonadotropin, beta Subunit, Human; 0/Peptide Fragments; 60-27-5/Creatinine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fetal ultrasonography in maternal PKU.
Next Document:  Rapid in situ harvesting and cytogenetic analysis of perinatal tissue samples.